FAFlávio Ferlin Arbex

Flávio Ferlin Arbex

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Flávio Ferlin Arbex has a total of 132 co-authors. Here are the top co-authors by number of shared publications:

  • Maria Clara N. Alencar

    Pulmonary Function and Clinical Exercise Physiology Unit (SEFICE), Division of Respirology, Federal University of Sao Paulo, Sao Paulo, Brazil

    11 shared publications
  • Jose Alberto Nedera

    Respiratory Investigation Unit, Division of Respirology, Department of Medicine, Queen's University, Kingston, ON, Canada

    9 shared publications
  • Priscila A. Sperandio

    Pulmonary Function and Clinical Exercise Physiology Unit (SEFICE), Division of Respirology, Federal University of Sao Paulo, Sao Paulo, Brazil

    9 shared publications
  • Alcides Rocha

    Pulmonary Function and Clinical Exercise Physiology Unit (SEFICE), Division of Respirology, Federal University of Sao Paulo, Sao Paulo, Brazil

    7 shared publications
  • Aline Souza

    Pulmonary Function and Clinical Exercise Physiology Unit (SEFICE), Division of Respirology, and

    6 shared publications
  • Daniel M. Hirai

    Pulmonary Function and Clinical Exercise Physiology Unit (SEFICE), Division of Respirology, Federal University of Sao Paulo, Sao Paulo, Brazil; Laboratory of Clinical Exercise Physiology and Respiratory Investigation Unit, Queen's University, Kingston General Hospital, Kingston, ON, Canada

    6 shared publications

Latest Publications

  • Open Access

    Sociodemographic and clinical characteristics of individuals exposed to smoking or biomass smoke and followed at primary health care centers in Brazil: a multicenter study

    by Juliana O Barros1, Flavio F Arbex2, Alcindo Cerci Neto3, Leandro G Fritscher4, Suzana E Tanni5, Gerson F Souza6, 7 Oliver A Nascimento1, José R Jardim1

    Objective: To describe the sociodemographic and clinical characteristics of individuals exposed to smoking or biomass smoke and followed at primary health care (PHC) centers across three states in Brazil. Methods: This was a cross-sectional multicenter study including patients followed at any of four PHC centers in Brazil. Patients = 35 years of age who were smokers or former smokers, or were exposed to biomass smoke were included, the exception being those with physical/mental disabilities and those who were pregnant. Face-to-face assessments included a questionnaire assessing clinical and sociodemographic characteristics, as well as the COPD Assessment Test (CAT) and the modified Medical Research Council (mMRC) dyspnea scale. Results: Of a total of 737 patients, 56.3% were female and 64.2% were White, with a mean age of 57.7 ± 11.8 years. Most (54.4%) had < 9 years of schooling, 50.2% had low socioeconomic status, and 71.5% were overweight/obese. Smokers accounted for 43.4% of the study sample, whereas 15.0% had no direct exposure to cigarette smoke. Common symptoms included cough, in 37.3%; wheezing, in 33.8%; and phlegm, in 27.4%. Most (75.1%) of the study participants had mMRC dyspnea scale scores of 0 or 1. CAT scores were 0-10, in 40.2%; 11-20, in 44.6%; 21-30, in 14.1%; and 31-40, in 1.1%. Binary logistic regression showed that sex and age significantly impacted mMRC dyspnea scale predictions, whereas BMI and socioeconomic status influenced CAT predictions. Common comorbidities included hypertension, in 51.3%; depression, in 27.4%; and diabetes, in 24.3%. No association was found between hypertension and obesity or smoking, or between diabetes and obesity or smoking. Conclusions: PHC patients with risk factors such as smoking and exposure to biomass smoke have a high comorbidity burden, with over half experiencing mild to moderate quality-of-life impacts. This study emphasizes the need for targeted preventive measures in PHC settings.


  • Open Access

    Effects of high- and moderate-intensity exercise on central hemodynamic and oxygen uptake recovery kinetics in CHF-COPD overlap

    by A. Mazzuco, A.S. Souza, W.M. Medeiros, P.A. Sperandio, M.C.N. Alencar, F.F. Arbex, J.A. Neder, A. Borghi-Silva

    The oxygen uptake (V˙O2) kinetics during onset of and recovery from exercise have been shown to provide valuable parameters regarding functional capacity of both chronic obstructive pulmonary disease (COPD) and chronic heart failure (CHF) patients. To investigate the influence of comorbidity of COPD in patients with CHF with reduced ejection fraction on recovery from submaximal exercise, 9 CHF-COPD male patients and 10 age-, gender-, and left ventricle ejection fraction (LVEF)-matched CHF patients underwent constant-load exercise tests (CLET) at moderate and high loads. The V˙O2, heart rate (HR), and cardiac output (CO) recovery kinetics were determined for the monoexponential relationship between these variables and time. Within-group analysis showed that the recovery time constant of HR (P0.05 in group vs load analysis). The ventilatory efficiency was related to MRT of V˙O2 during high CLET (r=0.71). Our results suggested that the combination of CHF and COPD may further impair the recovery kinetics compared to CHF alone.


  • Effects of bi-level positive airway pressure on ventilatory and perceptual responses to exercise in comorbid heart failure-COPD

    by Aline Souza, Priscila A. Sperandio, Adriana Mazzuco, Maria Clara N. Alencar, Flavio F. Arbex, Mayron Oliveira, Wladimir Medeiros, Alcides Rocha, Luiz E. Nery, Denis E. O.DOnnell, et al.


  • Open Access

    Muscle Mechanoreflex Control of Ventilation and Inspiratory Drive in Patients with Chronic Obstructive Pulmonary Disease

    by Liliane Aranda, Indyanara C Ribeiro, Luiza H Degani‐Costa, Flavio F Arbex, Hermanus Schoorlemmer, Lauro C Vianna, Luiz E Nery, Bruno M Silva

    Introduction: Activation of mechano‐ and metabo‐sensitive skeletal muscles afferents contributes to the regulation of exercise hyperpnea in healthy humans. Patients with chronic obstructive pulmonary disease (COPD) commonly have skeletal muscle dysfunction, which is likely accompanied by alteration in reflex ventilatory responses mediated by activation of skeletal muscle afferents. Objective: To investigate the effect of muscle mechanoreflex activation on ventilation and inspiratory drive in patients with COPD. Methods: Thirty four patients with COPD (FEV 1 = 48 ± 13% predicted, mean ± SEM) and 20 age‐ and sex‐matched healthy controls participated in the study. Muscle mechanoreceptors were activated by passive knee flexion and extension of the dominant leg. The passive movement was performed at 0.5 Hz for 30 s using an isokinetic dynamometer. Each trial was repeated at least four times. Superficial electrical activity of the vastus lateralis was monitored to confirm the absence of active contractions. Respiratory flow was continuously measured via a differential pressure pneumotachometer. Inspiratory flow (i.e., tidal volume divided by inspiratory time) and superficial electrical activity of the parasternal intercostals multiplied by the respiratory frequency (EMGpara index) provided proxies of the inspiratory drive. All data were interpolated to 1‐s intervals, time‐aligned across repetitions, and ensemble averaged. Baseline data were compared by the Student's t‐test. Responses to passive movement (Δ = passive movement minus baseline) were analyzed via two‐way repeated measures ANOVA, followed by Fisher's post hoc test. Data are reported as mean ± SEM. Statistical significance was set at P < 0.05. Results: At rest, patients with COPD presented higher ventilation, inspiratory flow and EMGpara index in comparison with controls. Passive movement increased ventilation, via increase in breathing frequency, as well as increased inspiratory flow and EMGpara index in both groups. However, patients with COPD presented blunted ventilatory (ΔCOPD = 0.527 ± 0.149 vs. Δcontrols = 1.099 ± 0.194 L/min, P = 0.01) and inspiratory flow (ΔCOPD = 0.011 ± 0.007 vs. Δcontrols = 0.036 ± 0.009 L/s, P = 0.03) responses during the first 10 s of the passive movement as compared to controls. The EMGpara index tended to be higher in patients with COPD at this time point (P = 0.06). During the final 10 s of the passive movement, the ventilatory response was similar between groups, whereas inspiratory flow (ΔCOPD = 0.061 ± 0.008 L/s vs. Δcontrols = 0.024 ± 0.011 L/s, P < 0.01) and EMGpara index (ΔCOPD = 54 ± 9 vs. Δcontrols = 24 ± 13 a.u., P = 0.046) responses were greater in patients with COPD as compared to controls. Conclusions: Patients with COPD had a slower ventilatory response and a higher inspiratory drive response to muscle mechanoreflex activation. The results suggest that the muscle mechanoreflex control of ventilation and inspiratory drive is abnormal in COPD which may be involved in the generation of exercise‐related dyspnea. Support or Funding Information The study was funded by (FAPESP: 2017/07771‐3). L.C.A. received a scholarship (CAPES). This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .


  • Exercise intolerance in comorbid COPD and heart failure: the role of impaired aerobic function

    by Alcides Rocha, Flavio F. Arbex, Priscila A. Sperandio, Frederico Mancuso, Mathieu Marillier, Anne-Catherine Bernard, Maria Clara N. Alencar, Denis E. O'DOnnell, J. Alberto Neder

    Impaired aerobic function is a potential mechanism of exercise intolerance in patients with combined cardiorespiratory disease. We investigated the pathophysiological and sensory consequences of a low change in oxygen uptake (ΔV′O2)/change in work rate (ΔWR) relationship during incremental exercise in patients with coexisting chronic obstructive pulmonary disease (COPD) and systolic heart failure (HF).After clinical stabilisation, 51 COPD–HF patients performed an incremental cardiopulmonary exercise test to symptom limitation. Cardiac output was non-invasively measured (impedance cardiography) in a subset of patients (n=18).27 patients presented with ΔV′O2/ΔWR below the lower limit of normal. Despite similar forced expiratory volume in 1 s and ejection fraction, the low ΔV′O2/ΔWR group showed higher end-diastolic volume, lower inspiratory capacity and lower transfer factor compared to their counterparts (pV′O2were ∼15% and ∼30% lower, respectively, in the former group: those findings were associated with greater symptom burden in daily life and at a given exercise intensity (leg discomfort and dyspnoea). The low ΔV′O2/ΔWR group presented with other evidences of impaired aerobic function (sluggishV′O2kinetics, earlier anaerobic threshold) and cardiocirculatory performance (lower oxygen pulse, lower stroke volume and cardiac output) (p<0.05). Despite similar exertional hypoxaemia, they showed worse ventilatory inefficiency and higher operating lung volumes, which led to greater mechanical inspiratory constraints (p<0.05).Impaired aerobic function due to negative cardiopulmonary–muscular interactions is an important determinant of exercise intolerance in patients with COPD–HF. Treatment strategies to improve oxygen delivery to and/or utilisation by the peripheral muscles might prove particularly beneficial to these patients.


  • Heart or Lungs? Uncovering the Causes of Exercise Intolerance in a Patient with Chronic Cardiopulmonary Disease

    by Alcides Rocha, Flavio F. Arbex, Priscila A. Sperandio, Frederico Mancuso, Maria Clara N. Alencar, Aline Souza, Ligia Biazzim, Denis E. O’dOnnell, J. Alberto Neder


  • Current challenges in managing comorbid heart failure and COPD

    by J. Alberto Neder, Alcides Rocha, Maria Clara N. Alencar, Flavio Arbex, Danilo C. Berton, Mayron F. Oliveira, Priscila A. Sperandio, Luiz E. Nery, Denis E. O’donnell

    Heart failure (HF) with reduced ejection fraction and chronic obstructive pulmonary disease (COPD) frequently coexist, particularly in the elderly. Given their rising prevalence and the contemporary trend to longer life expectancy, overlapping HF-COPD will become a major cause of morbidity and mortality in the next decade. Areas covered: Drawing on current clinical and physiological constructs, the consequences of negative cardiopulmonary interactions on the interpretation of pulmonary function and cardiopulmonary exercise tests in HF-COPD are discussed. Although those interactions may create challenges for the diagnosis and assessment of disease stability, they provide a valuable conceptual framework to rationalize HF-COPD treatment. The impact of COPD or HF on the pharmacological treatment of HF or COPD, respectively, is then comprehensively discussed. Authors finalize by outlining how the non-pharmacological treatment (i.e. rehabilitation and exercise reconditioning) can be tailored to the specific needs of patients with HF-COPD. Expert commentary: Randomized clinical trials testing the efficacy and safety of new medications for HF or COPD should include a sizeable fraction of patients with these coexistent pathologies. Multidisciplinary clinics involving cardiologists and respirologists trained in both diseases (with access to unified cardiorespiratory rehabilitation programs) are paramount to decrease the humanitarian and social burden of HF-COPD.


  • Top Cited Papers
    Open Access

    Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs

    by Denise Rossato Silva, Marcela Muñoz-Torrico, Raquel Duarte, Tatiana Galvão, Eduardo Henrique Bonini, Flávio Ferlin Arbex, Marcos Abdo Arbex, Valéria Maria Augusto, Marcelo Fouad Rabahi, Fernanda Carvalho de Queiroz Mello

    Tuberculosis continues to be a major public health problem. Although efforts to control the epidemic have reduced mortality and incidence, there are several predisposing factors that should be modified in order to reduce the burden of the disease. This review article will address some of the risk factors associated with tuberculosis infection and active tuberculosis, including diabetes, smoking, alcohol use, and the use of other drugs, all of which can also contribute to poor tuberculosis treatment results. Tuberculosis can also lead to complications in the course and management of other diseases, such as diabetes. It is therefore important to identify these comorbidities in tuberculosis patients in order to ensure adequate management of both conditions.


  • Excess Ventilation in Chronic Obstructive Pulmonary Disease–Heart Failure Overlap. Implications for Dyspnea and Exercise Intolerance

    by Alcides Rocha, Flavio F. Arbex, Priscilla A. Sperandio, Aline Souza, Ligia Biazzim, Frederico Mancuso, Danilo C. Berton, Bruno Hochhegger, Maria Clara N. Alencar, Luiz E. Nery, et al.

    Rationale: An increased ventilatory response to exertional metabolic demand (high V. e/V. co2 relationship) is a common finding in patients with coexistent chronic obstructive pulmonary disease and heart failure. Objectives: We aimed to determine the mechanisms underlying high V. e/V. co2 and its impact on operating lung volumes, dyspnea, and exercise tolerance in these patients. Methods: Twenty-two ex-smokers with combined chronic obstructive pulmonary disease and heart failure with reduced left ventricular ejection fraction undertook, after careful treatment optimization, a progressive cycle exercise test with capillary (c) blood gas collection. Measurements and Main Results: Regardless of the chosen metric (increased V. e–V. co2 slope, V. e/V. co2 nadir, or end-exercise V. e/V. co2), ventilatory inefficiency was closely related to PcCO2 (r values from −0.80 to −0.84; P < 0.001) but not dead space/tidal volume ratio. Ten patients consistently maintained exercise PcCO2 less than or equal to 35 mm Hg (hypocapnia). These patients had particularly poor ventilatory efficiency compared with patients without hypocapnia (P < 0.05). Despite the lack of between-group differences in spirometry, lung volumes, and left ventricular ejection fraction, patients with hypocapnia had lower resting PaCO2 and lung diffusing capacity (P < 0.01). Excessive ventilatory response in this group was associated with higher exertional PcO2. The group with hypocapnia, however, had worse mechanical inspiratory constraints and higher dyspnea scores for a given work rate leading to poorer exercise tolerance compared with their counterparts (P < 0.05). Conclusions: Heightened neural drive promoting a ventilatory response beyond that required to overcome an increased “wasted” ventilation led to hypocapnia and poor exercise ventilatory efficiency in chronic obstructive pulmonary disease–heart failure overlap. Excessive ventilation led to better arterial oxygenation but at the expense of earlier critical mechanical constraints and intolerable dyspnea.


  • Physiological and clinical relevance of exercise ventilatory efficiency in COPD

    by J. Alberto Neder, Danilo C. Berton, Flavio F. Arbex, Maria Clara Alencar, Alcides Rocha, Priscila A. Sperandio, Paolo Palange, Denis E. O'Donnell

    Exercise ventilation (V′E) relative to carbon dioxide output (V′CO2) is particularly relevant to patients limited by the respiratory system,e.g.those with chronic obstructive pulmonary disease (COPD). HighV′E−V′CO2(poor ventilatory efficiency) has been found to be a key physiological abnormality in symptomatic patients with largely preserved forced expiratory volume in 1 s (FEV1). Establishing an association between highV′E−V′CO2and exertional dyspnoea in mild COPD provides evidence that exercise intolerance is not a mere consequence of detraining. As the disease evolves, poor ventilatory efficiency might help explaining “out-of-proportion” breathlessness (to FEV1impairment). Regardless, disease severity, cardiocirculatory co-morbidities such as heart failure and pulmonary hypertension have been found to increaseV′E−V′CO2. In fact, a highV′E−V′CO2has been found to be a powerful predictor of poor outcome in lung resection surgery. Moreover, a highV′E−V′CO2has added value to resting lung hyperinflation in predicting all-cause and respiratory mortality across the spectrum of COPD severity. Documenting improved ventilatory efficiency after lung transplantation and lung volume reduction surgery provides objective evidence of treatment efficacy. Considering the usefulness of exercise ventilatory efficiency in different clinical scenarios, theV′E−V′CO2relationship should be valued in the interpretation of cardiopulmonary exercise tests in patients with mild-to-end-stage COPD.